413 related articles for article (PubMed ID: 19414792)
1. Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome.
Orth D; Khan AB; Naim A; Grif K; Brockmeyer J; Karch H; Joannidis M; Clark SJ; Day AJ; Fidanzi S; Stoiber H; Dierich MP; Zimmerhackl LB; Würzner R
J Immunol; 2009 May; 182(10):6394-400. PubMed ID: 19414792
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.
Poolpol K; Orth-Höller D; Speth C; Zipfel PF; Skerka C; de Córdoba SR; Brockmeyer J; Bielaszewska M; Würzner R
Mol Immunol; 2014 Mar; 58(1):77-84. PubMed ID: 24317278
[TBL] [Abstract][Full Text] [Related]
3. Complement in typical hemolytic uremic syndrome.
Orth D; Würzner R
Semin Thromb Hemost; 2010 Sep; 36(6):620-4. PubMed ID: 20865638
[TBL] [Abstract][Full Text] [Related]
4. Role of complement in enterohemorrhagic Escherichia coli-Induced hemolytic uremic syndrome.
Orth-Höller D; Würzner R
Semin Thromb Hemost; 2014 Jun; 40(4):503-7. PubMed ID: 24799304
[TBL] [Abstract][Full Text] [Related]
5. [Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection].
Prado V; Cordero J; Garreaud C; Olguin H; Arellano C; Nachar CL; Misraji A; Martínez J; Tous M; Rivas M
Rev Med Chil; 1995 Jan; 123(1):13-22. PubMed ID: 7569441
[TBL] [Abstract][Full Text] [Related]
6. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome.
Karch H
Semin Thromb Hemost; 2001 Jun; 27(3):207-13. PubMed ID: 11446654
[TBL] [Abstract][Full Text] [Related]
7. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].
Allerberger F; Sölder B; Caprioli A; Karch H
Wien Klin Wochenschr; 1997 Sep; 109(17):669-77. PubMed ID: 9381722
[TBL] [Abstract][Full Text] [Related]
8. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
[TBL] [Abstract][Full Text] [Related]
9. [Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli].
Ibarra C; Goldstein J; Silberstein C; Zotta E; Belardo M; Repetto HA
Arch Argent Pediatr; 2008 Oct; 106(5):435-42. PubMed ID: 19030644
[TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans.
Orth D; Grif K; Zimmerhackl LB; Würzner R
Expert Rev Anti Infect Ther; 2008 Feb; 6(1):101-8. PubMed ID: 18251667
[TBL] [Abstract][Full Text] [Related]
11. Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells.
Ehrlenbach S; Rosales A; Posch W; Wilflingseder D; Hermann M; Brockmeyer J; Karch H; Satchell SC; Würzner R; Orth-Höller D
Infect Immun; 2013 Aug; 81(8):2678-85. PubMed ID: 23690395
[TBL] [Abstract][Full Text] [Related]
12. Treatment of typical (enteropathic) hemolytic uremic syndrome.
Bitzan M; Schaefer F; Reymond D
Semin Thromb Hemost; 2010 Sep; 36(6):594-610. PubMed ID: 20865636
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome.
Tazzari PL; Ricci F; Carnicelli D; Caprioli A; Tozzi AE; Rizzoni G; Conte R; Brigotti M
Cytometry B Clin Cytom; 2004 Sep; 61(1):40-4. PubMed ID: 15351981
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and pathogenesis of enterohaemorrhagic Escherichia coil.
Karch H; Mellmann A; Bielaszewska M
Berl Munch Tierarztl Wochenschr; 2009; 122(11-12):417-24. PubMed ID: 19999376
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
Yamada S; Shimizu M; Kuroda M; Inoue N; Sugimoto N; Yachie A
Clin Exp Nephrol; 2019 Apr; 23(4):544-550. PubMed ID: 30467800
[TBL] [Abstract][Full Text] [Related]
16. Enterohaemorrhagic Escherichia coli O26:H11/H-: a human pathogen in emergence.
Bielaszewska M; Zhang W; Mellmann A; Karch H
Berl Munch Tierarztl Wochenschr; 2007; 120(7-8):279-87. PubMed ID: 17715820
[TBL] [Abstract][Full Text] [Related]
17. [Hemolytic uremic syndrome].
Rota S; Cravedi P; Remuzzi G; Ruggenenti P
G Ital Nefrol; 2005; 22 Suppl 33():S57-64. PubMed ID: 16419008
[TBL] [Abstract][Full Text] [Related]
18. [Hemolytic and uremic syndrome and maternal-fetal Escherichia coli K1 infection].
Flandrois M; Bessière A; Vieira-Roth S; Vergnaud M; Frémeaux-Bacchi V; Eckart P
Arch Pediatr; 2011 Mar; 18(3):283-6. PubMed ID: 21269814
[TBL] [Abstract][Full Text] [Related]
19. Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome.
Arvidsson I; Ståhl AL; Hedström MM; Kristoffersson AC; Rylander C; Westman JS; Storry JR; Olsson ML; Karpman D
J Immunol; 2015 Mar; 194(5):2309-18. PubMed ID: 25637016
[TBL] [Abstract][Full Text] [Related]
20. Elevated tissue factor circulating levels in children with hemolytic uremic syndrome caused by verotoxin-producing E. coli.
Kamitsuji H; Nonami K; Murakami T; Ishikawa N; Nakayama A; Umeki Y
Clin Nephrol; 2000 May; 53(5):319-24. PubMed ID: 11305804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
